Detalhe da pesquisa
1.
Five-year Results from the Prospective, Multicenter, Observational SOUNDS Study of Patients with Overactive Bladder Treated with the InterStim System for Sacral Neuromodulation.
Eur Urol Focus
; 9(5): 765-772, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37019729
2.
Sacral Neuromodulation with the InterStim System for Overactive Bladder: 3-Year Results from the French Prospective, Multicenter, Observational SOUNDS Study.
Eur Urol Focus
; 8(5): 1399-1407, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34334342
3.
Sacral Neuromodulation with the InterStim™ System for Intractable Lower Urinary Tract Dysfunctions (SOUNDS): Results of Clinical Effectiveness, Quality of Life, Patient-Reported Outcomes and Safety in a French Multicenter Observational Study.
Eur Urol Focus
; 7(6): 1430-1437, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32907782
4.
Preclinical assessment of gastrooesophageal tolerance of the new antiosteoporotic drug strontium ranelate: an endoscopic study in monkeys.
Basic Clin Pharmacol Toxicol
; 98(5): 442-6, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16635101
5.
[Prostatic sarcoma: Report of two cases]. / Les tumeurs sarcomateuses de prostate: à propos de deux cas.
Prog Urol
; 16(5): 613-6, 2006 Nov.
Artigo
em Francês
| MEDLINE | ID: mdl-17175964